Adaption and National Validation of a Tool for Predicting Mortality from Other Causes Among Men with Nonmetastatic Prostate Cancer
-
Published:2024-08
Issue:4
Volume:7
Page:923-932
-
ISSN:2588-9311
-
Container-title:European Urology Oncology
-
language:en
-
Short-container-title:European Urology Oncology
Author:
Justice Amy C.ORCID,
Tate Janet P.,
Howland Frank,
Gaziano J. Michael,
Kelley Michael J.,
McMahon Benjamin,
Haiman Christopher,
Wadia Roxanne,
Madduri Ravi,
Danciu Ioana,
Leppert John T.,
Leapman Michael S.,
Thurtle David,
Gnanapragasam Vincent J.
Reference56 articles.
1. Prostate cancer incidence and survival, by stage and race/ethnicity—United States, 2001–2017;Siegel;MMWR Morb Mortal Wkly Rep,2020
2. Prostate cancer in elderly men;Stangelberger;Rev Urol,2008
3. Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options;Sanda;J Urol,2018
4. Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology;Mohler;J Natl Compr Canc Netw,2019
5. Estimating patient health in prostate cancer treatment counseling;Chesnut;Prostate Cancer Prostatic Dis,2023